The present study deals with the description of a new piscine trypanosome species found infecting the fresh water fish Schizothorax plagiostomus Heckel from river Jhelum, Srinagar, J&K, India and evaluating the haematological parameters of the infected fish. Haematological examination of S. plagiostomus revealed 61.1 % infection with an intensity of 1-9 trypanosomes/100 RBC's. Small (26.9 ± 1.39 lm) and large (47.17 ± 3.50 lm) forms of the trypanosome were observed in light microscopy investigations, revealing the dimorphic nature of the species. The trypanosome species was found to be distinct from the other related dimorphic species in morphometric dimensions including cell length, cell breadth, kinetoplast index, flagellar index, and cytological peculiarities, respectively. The detailed descriptions of the two morphological forms found in the blood of S. plagiostomus are provided. Based on the geographical location, morphometrics, cytological peculiarities, host status and comparative study, the new species is named Trypanosoma kashmirensis n. sp. The parasitic infestation caused a significant decrease (p \ 0.05) in red blood cell counts, haematocrit and haemoglobin concentrations while, the leucocyte (WBC) count, mean cellular volume and mean cellular haemoglobin showed a significant increase (p \ 0.05) in the infected fish as compared to the non-infected. The above alterations of the haematological parameters could be used as an important tool for the indication of Trypanosoma infection in the fish.
Background: The rapid changes in practice of radiotherapy have taken place over the past 5 years in Pakistan. With advent of computed tomography simulator, and multileaf collimators–assisted linear accelerators and electronic portal imaging system, few centres in Pakistan have switched from conventional radiotherapy to modern computer-based technology. Our hospital is first centre in Pakistan which is using virtual simulation since March 2006. We present our experience with list of merits and demerits.Design: Retrospective study.Patient collection: Medical records of all patients who received radiotherapy in our centre were reviewed. Parameters included were type of malignancy, type radiotherapy (curative/palliative), simulation and planning process time and the displacement of the beam-axis from the planning isocentre in clinical situations during three-dimensional conformal radiotherapy using electronic portal imaging device (EPID). Data were collected on written proforma. Percentages, frequencies, measures of central tendency and dispersion were calculated using SPSS version 17.0.Results: A total of 289 patients were treated from March 2006 to November 2008. Transitional cell carcinoma of urinary bladder was most common malignancy seen (42.4%) followed by prostate (28.62%) and renal cell carcinoma (14.14%). Of these 34.26% patients were treated on curative basis. The virtual simulation process could be completed in an average time of 5 min (SD 3.5). Under many cases, the treatment portals could be designed and the patient marked in one session. The displacements were recorded for 43 portals for early prostate cancer using an EPID system. The mean displacement was found 2.44 ± 0.8 mm in x (transverse), y (craniocaudal), and z (anteroposterior) directions during treatment. Standard deviation (SD) was 0.87 (90% CI 2.21–2.66). Average number of portals taken was 10 (6–27) per treatment session.Conclusion: Computer-based simulation and treatment over conventional methods is appropriate for curative patients, achieving more accurate tumour localisation, sparing normal organs at risk, reduced field sizes and a film free environment; however efforts are required to achieve maximum immobilisation during treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.